Study cohort | |
---|---|
Number | 4160 |
Age (years) | 79 (66, 86) |
Gender | |
Male | 1941 (46.7%) |
Female | 2219 (53.3%) |
Charlson Index | |
0 | 1467 (35.3%) |
1 | 1199 (28.8%) |
≥2 | 1494 (35.9%) |
Diagnosis of heart failure | 1035 (24.9%) |
Length of admission (days) | 11.8 (8.9, 17.3) |
Deceased at 30 days | 189 (4.5%) |
Deceased at 12 months | 716 (17.2%) |
Liver tests on admission | |
Albumin (g/L) | 35 (31, 38) |
Bilirubin (µmol/L) | 10 (6, 14) |
ALP (U/L) | 88 (69, 116) |
GGT (U/L) | 41 (24, 84) |
ALT (U/L) | 21 (14, 35) |
AST (U/L) | 31 (23, 46) |
Data are presented as median (IQR) or number (percentage).
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma glutamyl transferase.